ENTITY
Simcere Pharmaceutical

Simcere Pharmaceutical (2096 HK)

111
Analysis
Health Care • China
Simcere Pharmaceutical Group is an innovation and R&D-driven pharmaceutical company engaged in the research, development, manufacturing, and sale of pharmaceutical products. It focuses on therapeutic areas such as oncology, central nervous system diseases, autoimmune diseases, and anti-infection, with key products including Sanbexin, Endostar, and Bicun. The company was founded in 1995 and is headquartered in Nanjing, China.
more
•08 Jul 2020 14:37

Simcere (先声制药) Pre-IPO: Long History but Products Concentrated

Simcere Pharma has a long history dating back to 1995 and was previously listed in the US. The company is looking to raise USD 500m via a listing...

Logo
705 Views
Share
x